Zura Bio
Sandeep Kulkarni is a Board Member at Zura Bio Limited and currently serves as the Chief Executive Officer at Tourmaline Bio. Previously, Sandeep held positions as a Managing Director at KVP Capital, Vice President Special Projects at Roivant Sciences, and Chief Operating Officer at Immunovant. With a background in investment analysis at QVT Financial LP, Sandeep holds a MD degree from the University of California, San Francisco - School of Medicine and an AB in Economics from Harvard University.
This person is not in the org chart
This person is not in any teams
Zura Bio
1 followers
Zura Bio is a multi-asset clinical-stage biotechnology company focused on developing novel medicines for immune and inflammatory disorders. Currently, Zura Bio is developing three assets which have completed phase 1/1b studies and are Phase 2 ready. The company is developing a portfolio of therapeutic indications for tibulizumab (ZB-106), torudokimab (ZB-880), and ZB-168 with a goal of demonstrating their efficacy, safety, and dosing convenience in immune and inflammatory disorders. Zura Bio is headquartered in Henderson, NV with team members in the UK and USA.